Contra-indicated in patients with a tendency towards hypercalcemia or current evidence of vitamin D toxicity.
- TRADE NAME: Hectorol (Genzyme)
- INDICATIONS: Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
- CLASS: Vitamin D receptor agonist
- HALF-LIFE: 32–37 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminoglutethimide, Cholestyramine, Erythromycin, Ketoconazole, Magnesium-containing antacids, Mineral oil, Phenobarbital
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
